Plato Investment Management LTD Janux Therapeutics, Inc. Transaction History
Plato Investment Management LTD
- $1.23 Trillion
- Q3 2024
A detailed history of Plato Investment Management LTD transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Plato Investment Management LTD holds 1,186 shares of JANX stock, worth $63,949. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,186
Previous 999
18.72%
Holding current value
$63,949
Previous $41.8 Million
28.62%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding JANX
# of Institutions
160Shares Held
37.3MCall Options Held
70.4KPut Options Held
101K-
Ra Capital Management, L.P. Boston, MA9.17MShares$494 Million5.79% of portfolio
-
Orbimed Advisors LLC San Diego, CA2.98MShares$161 Million3.01% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$126 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.33MShares$126 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X01.8MShares$97.2 Million0.04% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $2.25B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...